1. Home
  2. NSSC vs WVE Comparison

NSSC vs WVE Comparison

Compare NSSC & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NAPCO Security Technologies Inc.

NSSC

NAPCO Security Technologies Inc.

HOLD

Current Price

$37.95

Market Cap

1.4B

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$6.24

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSSC
WVE
Founded
1969
2012
Country
United States
Singapore
Employees
1061
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.1B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
NSSC
WVE
Price
$37.95
$6.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
16
Target Price
$48.17
$29.81
AVG Volume (30 Days)
464.1K
3.3M
Earning Date
05-04-2026
04-28-2026
Dividend Yield
1.33%
N/A
EPS Growth
N/A
N/A
EPS
0.70
N/A
Revenue
$181,621,000.00
$3,704,000.00
Revenue This Year
$13.63
N/A
Revenue Next Year
$10.05
$85.67
P/E Ratio
$54.86
N/A
Revenue Growth
N/A
149.43
52 Week Low
$29.27
$5.02
52 Week High
$47.61
$21.73

Technical Indicators

Market Signals
Indicator
NSSC
WVE
Relative Strength Index (RSI) 51.37 52.15
Support Level $37.43 $6.02
Resistance Level $38.25 $6.31
Average True Range (ATR) 1.16 0.30
MACD 0.23 0.10
Stochastic Oscillator 56.41 72.43

Price Performance

Historical Comparison
NSSC
WVE

About NSSC NAPCO Security Technologies Inc.

NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses. Geographically, the company derives a majority of its revenue from the United States.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: